Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Recursion Pharmaceuticals Inc., 3 years.
Recursion Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +5,109 | — | — |
| Jun 17, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +88,424 | — | — |
| Apr 1, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +4,902 | — | — |
| Jan 2, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +3,571 | — | — |
| Oct 1, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +2,941 | — | — |
| Jul 1, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +2,924 | — | — |
| Jun 18, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +22,016 | — | — |
| Apr 1, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +2,745 | — | — |
| Jan 2, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +1,907 | — | — |
| Oct 1, 2024 | Recursion Pharmaceuticals Inc. | Grant or award | +2,229 | — | — |
| Jul 1, 2024 | Recursion Pharmaceuticals Inc. | Grant or award | +1,843 | — | — |
| Jun 3, 2024 | Recursion Pharmaceuticals Inc. | Grant or award | +13,097 | — | — |
| Apr 1, 2024 | Recursion Pharmaceuticals Inc. | Grant or award | +1,467 | — | — |
| Jan 2, 2024 | Recursion Pharmaceuticals Inc. | Grant or award | +1,393 | — | — |
| Dec 14, 2023 | Recursion Pharmaceuticals Inc. | Open-market sale | −20,141 | $9.00 | $181,269 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.